Adverse outcome pathway on inhibition of thyroperoxidase and subsequent adverse neurodevelopmental outcomes in mammals - Crofton, KM; Gilbert, M; Friedman, KP (OECD Series on Adverse Outcome Pathways, No. 13, 2019)